Cohorts | Variables | AUC | Cutoff | SEN | SPE | PPV | NPV | ACU |
---|---|---|---|---|---|---|---|---|
Primary cohort | Y1 | 0.946 (0.902–0.990) | 2.1a | 0.885 | 0.933 | 0.828 | 0.959 | 0.922 |
Y2 | 0.953 (0.909–0.997) | 2.58a | 0.923 | 0.947 | 0.862 | 0.973 | 0.941 | |
Trachea invasion | 0.709 (0.579–0.838) | Yes | 0.444 | 0.973 | 0.857 | 0.839 | 0.833 | |
Tumor range | 0.756 (0.660–0.853) | 3/4–1 | 0.926 | 0.587 | 0.49 | 0.973 | 0.676 | |
T stage | 0.726 (0.600–0.852) | T4b | 0.519 | 0.933 | 0.737 | 0.843 | 0.824 | |
Location | 0.696 (0.582–0.809) | Mid-thorax | 0.778 | 0.613 | 0.885 | 0.42 | 0.657 | |
Deep ulcer | 0.874 (0.782–0.966) | Yes | 0.815 | 0.933 | 0.815 | 0.933 | 0.902 | |
Validation cohort | Y1 | 0.841 (0.758–0.924) | 2.1a | 0.63 | 0.84 | 0.586 | 0.863 | 0.784 |
Y2 | 0.917 (0.864–0.969) | 2.58a | 0.63 | 0.827 | 0.567 | 0.861 | 0.775 | |
Trachea invasion | 0.524 (0.392–0.655) | Yes | 0.154 | 0.893 | 0.333 | 0.753 | 0.696 | |
Tumor range | 0.648 (0.531–0.745) | 3/4–1 | 0.741 | 0.569 | 0.37 | 0.854 | 0.598 | |
T stage | 0.562 (0.429–0.696) | T4b | 0.778 | 0.893 | 0.429 | 0.761 | 0.716 | |
Location | 0.584 (0.470–0.699) | Mid-thorax | 0.63 | 0.587 | 0,354 | 0.815 | 0.598 | |
Deep ulcer | 0.767 (0.649–0.885) | Yes | 0.667 | 0.88 | 0.148 | 0.867 | 0.676 |